J Gómez-Ambrosi1,2,3, P Andrada4, V Valentí2,3,5, F Rotellar5, C Silva2,3,4, V Catalán1,2,3, A Rodríguez1,2,3, B Ramírez1,2,3, R Moncada2,3,6, J Escalada2,4, J Salvador2,4, G Frühbeck1,2,3,4. 1. Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain. 2. Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Pamplona, Spain. 3. Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain. 4. Department of Endocrinology and Nutrition, Clínica Universidad de Navarra, Pamplona, Spain. 5. Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain. 6. Department of Anaesthesia, Clínica Universidad de Navarra, Pamplona, Spain.
Abstract
BACKGROUND/ OBJECTIVES: Body weight, body mass index (BMI) and excess weight loss (EWL) are the most frequently used measures to analyse bariatric surgery outcomes. However, these measurements do not provide accurate information on body composition (BC) with body fat (BF), importantly determining the levels of cardiometabolic risk factors. Our aim was to analyse the evolution of BC after Roux-en-Y Gastric Bypass (RYGB) and its influence on the changes of cardiometabolic risk factors in comparison to BMI and EWL. SUBJECTS/ METHODS: A group of 81 obese Caucasian patients (19 males/62 females) aged 44.9±1.3 years undergoing RYGB between January 2006 and December 2011 was prospectively followed up for a period of 3 years. BC was determined by air-displacement plethysmography. Visceral adiposity, physical activity and cardiometabolic risk factors were measured. RESULTS: BF was markedly (P<0.001) reduced after the first year, increasing progressively during the second and third years after RYGB, following a different trajectory than body weight, BMI and EWL that decreased up to the second year post surgery. Markers of glucose homeostasis decreased during the first month and continued to decrease during the first year (P<0.05), remaining stabilised or slightly increased between the second and third years following RYGB. However, markers of lipid metabolism decreased (P<0.05) markedly during the first 12 months, increasing thereafter in parallel to the changes observed in BC, with the exception of high-density lipoprotein-cholesterol, which increased progressively throughout the whole period analysed. CONCLUSIONS: The adverse switch in the changes in BC between the first and the second years after RYGB may underlie the changes observed in cardiometabolic risk factors. Tracking of adiposity during the follow-up of bariatric/metabolic surgery yields clinically relevant information to better identify patients in need of increased lifestyle advice or treatment intensification.
BACKGROUND/ OBJECTIVES: Body weight, body mass index (BMI) and excess weight loss (EWL) are the most frequently used measures to analyse bariatric surgery outcomes. However, these measurements do not provide accurate information on body composition (BC) with body fat (BF), importantly determining the levels of cardiometabolic risk factors. Our aim was to analyse the evolution of BC after Roux-en-Y Gastric Bypass (RYGB) and its influence on the changes of cardiometabolic risk factors in comparison to BMI and EWL. SUBJECTS/ METHODS: A group of 81 obese Caucasian patients (19 males/62 females) aged 44.9±1.3 years undergoing RYGB between January 2006 and December 2011 was prospectively followed up for a period of 3 years. BC was determined by air-displacement plethysmography. Visceral adiposity, physical activity and cardiometabolic risk factors were measured. RESULTS: BF was markedly (P<0.001) reduced after the first year, increasing progressively during the second and third years after RYGB, following a different trajectory than body weight, BMI and EWL that decreased up to the second year post surgery. Markers of glucose homeostasis decreased during the first month and continued to decrease during the first year (P<0.05), remaining stabilised or slightly increased between the second and third years following RYGB. However, markers of lipid metabolism decreased (P<0.05) markedly during the first 12 months, increasing thereafter in parallel to the changes observed in BC, with the exception of high-density lipoprotein-cholesterol, which increased progressively throughout the whole period analysed. CONCLUSIONS: The adverse switch in the changes in BC between the first and the second years after RYGB may underlie the changes observed in cardiometabolic risk factors. Tracking of adiposity during the follow-up of bariatric/metabolic surgery yields clinically relevant information to better identify patients in need of increased lifestyle advice or treatment intensification.
Authors: Franziska Huettner; Charalambos K Rammos; Danuta I Dynda; Melinda L Lange; J Stephen Marshall; Thomas R Rossi; James R DeBord Journal: Am Surg Date: 2012-06 Impact factor: 0.688
Authors: Torsten Olbers; Sofia Björkman; Ak Lindroos; Almantas Maleckas; Lars Lönn; Lars Sjöström; Hans Lönroth Journal: Ann Surg Date: 2006-11 Impact factor: 12.969
Authors: Anita P Courcoulas; Steven H Belle; Rebecca H Neiberg; Sheila K Pierson; Jessie K Eagleton; Melissa A Kalarchian; James P DeLany; Wei Lang; John M Jakicic Journal: JAMA Surg Date: 2015-10 Impact factor: 14.766
Authors: Javier Gómez-Ambrosi; Javier Salvador; Jose A Páramo; Josune Orbe; Jokin de Irala; Alberto Diez-Caballero; María J Gil; Javier A Cienfuegos; Gema Frühbeck Journal: Clin Biochem Date: 2002-06 Impact factor: 3.281
Authors: Carolina Ferreira Nicoletti; José Simon Camelo; José Ernesto dos Santos; Julio Sergio Marchini; Wilson Salgado; Carla Barbosa Nonino Journal: Nutrition Date: 2013-10-31 Impact factor: 4.008
Authors: Alberto Benetti; Marina Del Puppo; Andrea Crosignani; Annamaria Veronelli; Enzo Masci; Francesca Frigè; Giancarlo Micheletto; Valerio Panizzo; Antonio E Pontiroli Journal: Diabetes Care Date: 2012-12-28 Impact factor: 19.112
Authors: Wendy C King; Jia-Yuh Chen; Dale S Bond; Steven H Belle; Anita P Courcoulas; Emma J Patterson; James E Mitchell; William B Inabnet; George F Dakin; David R Flum; Brian Cook; Bruce M Wolfe Journal: Obesity (Silver Spring) Date: 2015-06 Impact factor: 5.002
Authors: Verónica Vázquez-Velázquez; Alexandra Rodríguez González; Samuel Ordoñez Ortega; Marcela Rodríguez Flores; Miguel F Herrera; Juan Pablo Pantoja; Mauricio Sierra; Claudia González-Jáuregui Prida; Juan Eduardo García García Journal: Obes Surg Date: 2018-03 Impact factor: 4.129
Authors: Belén Pérez-Pevida; Javier Escalada; Alexander D Miras; Gema Frühbeck Journal: Front Endocrinol (Lausanne) Date: 2019-09-19 Impact factor: 5.555
Authors: Friedrich C Jassil; Alisia Carnemolla; Helen Kingett; Bruce Paton; Aidan G O'Keeffe; Jacqueline Doyle; Stephen Morris; Neville Lewis; Amy Kirk; Andrea Pucci; Kusuma Chaiyasoot; Rachel L Batterham Journal: BMJ Open Date: 2018-03-16 Impact factor: 2.692
Authors: Daniel Eriksson Hogling; Jesper Bäckdahl; Anders Thorell; Mikael Rydén; Daniel P Andersson Journal: Obes Surg Date: 2020-03 Impact factor: 4.129
Authors: Rebeca Rocha de Almeida; Márcia Ferreira Cândido de Souza; Dihogo Gama de Matos; Larissa Monteiro Costa Pereira; Victor Batista Oliveira; Joselina Luzia Menezes Oliveira; José Augusto Soares Barreto-Filho; Marcos Antonio Almeida-Santos; Raphael Fabrício de Souza; Aristela de Freitas Zanona; Victor Machado Reis; Felipe J Aidar; Antônio Carlos Sobral Sousa Journal: Int J Environ Res Public Health Date: 2019-11-27 Impact factor: 3.390